THE REPLACE REGISTRY

Serial Number 90610195
602

Registration Progress

Application Filed
Mar 29, 2021
Under Examination
Nov 7, 2023
Approved for Publication
Sep 12, 2023
Published for Opposition
Sep 12, 2023
Registered

Trademark Image

THE REPLACE REGISTRY

Basic Information

Serial Number
90610195
Filing Date
March 29, 2021
Published for Opposition
September 12, 2023
Abandonment Date
February 3, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Feb 20, 2025
Classes
042

Rights Holder

MIRUM PHARMACEUTICALS, INC.

03
Address
989 E HILLSDALE BLVD., SUITE 300
FOSTER CITY, CA 94404

Ownership History

Travere Therapeutics, Inc.

Original Applicant
03
San Diego, CA

Travere Therapeutics, Inc.

Owner at Publication
03
San Diego, CA

MIRUM PHARMACEUTICALS, INC.

New Owner After Publication #1
03
FOSTER CITY, CA

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

All Deadlines Cleared

All 9 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description Documents
Feb 20, 2025 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Feb 20, 2025 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Dec 18, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 18, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 18, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 18, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 18, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 4, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Nov 4, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Oct 30, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 2, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 2, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 2, 2024 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
May 16, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 16, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 23, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 23, 2024 IUAF S USE AMENDMENT FILED Loading...
Nov 7, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 12, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 12, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 23, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 7, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 27, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 26, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 26, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Apr 27, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Apr 27, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 27, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 27, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 27, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 27, 2023 ALIE A ASSIGNED TO LIE Loading...
Jan 9, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 7, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 7, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jul 7, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 6, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 5, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 5, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 5, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 5, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 5, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 29, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 5, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 1, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
registry services, namely, conducting a registry study in the field of pharmaceuticals and providing educational information in the nature of study results in the field of pharmaceuticals for the purpose of educating healthcare practitioners

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"REGISTRY"